FDA greenlights 1st anti-inflammatory drug for cardiovascular disease

The FDA approved the first anti-inflammatory atheroprotective cardiovascular treatment to reduce risk of cardiovascular events

Related Keywords

Michael Blaha ,Johns Hopkins Ciccarone Center ,Baltimore Based Johns Hopkins Ciccarone Center ,Cardiovascular Disease ,Fda ,Anti Inflammatory ,Ardiovascular ,Heart Treatment ,Cardiovascular Risk ,Bodoco ,Stroke ,Myocardial Infarction ,Coronary Revascularization ,Heart Medication ,